UASt regulatory sequences drive expression of an inverted repeat.
Scer\GAL4Ilp2.PR-mediated expression results in a significant reduction in the body weight of emerging adults compared to controls.
Expression under the control of Scer\GAL41407 results in loss of neuroblasts in the larval brain associated with decreased size of the remaining neuroblasts.
Expression under the control of Scer\GAL41407 results in a reduction in the average size of neuroblasts together with shorter neuroblast lineages (less daughter cells per neuroblast) in the larval brain compared to controls.
Expression under the control of Scer\GAL41407 results in mild defects in the shape of neuroblasts in the larval brain.
Adults expressing Tsr1GD12206 under the control of Scer\GAL4elav.PLu (in the presence of Dcr-2Scer\UAS.cDa to increase the efficiency of RNAi) do not show a significant defect in avoidance of noxious temperature (46[o]C) compared to control flies.
Expression of Tsr1GD12206 under the control of Scer\GAL4elav.PLu (in the presence of Dcr-2Scer\UAS.cDa to increase the efficiency of RNAi) results in viable flies or partial lethality, depending on the particular P{GD12206} insertion line used.
Expression under the control of Scer\GAL4Mef2.PR results in early larval lethality.
Expression under the control of Scer\GAL4Mef2.PR results in grossly normal larval body wall muscles.
Expression under the control of Scer\GAL4Mef2.PR results in wild-type sarcomeres in the larval body wall muscles.
Expression under the control of Scer\GAL4pnr-MD237 may result in lethality, depending on the insertion line used.